Clinical Trial Detail

NCT ID NCT02367456
Title A Combination Study of PF-04449913 (Glasdegib) and Azacitidine In 1st Line MDS, AML and CMML Patients
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Pfizer
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

Azacitidine + Glasdegib

Age Groups: adult

No variant requirements are available.